Expression of apoptosis-related proteins in model of anoxia in vitro

Folia Neuropathologica

Volumn 43, Issue 1, 2005, Pages 23-29

  Nagańska, Ewa ^a   Matyja, Ewa ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Anoxia in vitro; Apoptosis related proteins; Immunoreactivity; TPEN; Zinc

Indexed keywords

CHELATING AGENT; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; ZINC;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL LOSS; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; HIPPOCAMPUS; IMMUNOREACTIVITY; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 17344364218     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Banasiak JK, Haddad GG. Hypoxia-induced apoptosis: effect of hypoxic severity and role of D53 in neuronal cell death. Brain Res 1998; 797: 295-304.
2. Banasiak KJ, Cronin T, Haddad GG. bcl-2 prolongs neuronal survival during hypoxia-induced apoptosis. Brain Res Mol Brain Res 1999; 72: 214-225.
3. Bernier PJ, Parent A. Bcl-2 protein as a marker of neuronal immaturity in postnatal primate brain. J Neurosci 1998; 1: 2486-2497.
4. Bossenmeyer-Pourie C, Lievre V, Grojean S, Koziel V, Pillot T, Daval JL. Sequential expression patterns of apoptosis- and cell cycle-related oroteins in neuronal response to severe or mild transient hypoxia. Neuroscience 2002; 114: 869-882.
5. Chen J, Graham SH, Chan PH, Lan J, Zhou RL, Simon RP. bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport 1995; 26: 394-398.
6. Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A, Cox MC, Franchi A, Bruno A, Mazzone C, Panetta P, Suppo G, Masi M, Amadori S. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003; 15: 2125-2131.
7. Deshpande J, Bergstedt K, Linden T, Kalimo H, Wieloch T. Ultrastructural changes in the hippocampa CA1 region following transient cerebral ishchemia: evidence against programmed cell death. Exp Brain Res 1992; 88: 91-105.
8. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994; 15: 3253-3259.
9. Dux E., Oschlies U., Uto A., Kusumoto M., Hossmann KA. Early ultrastructural changes after brief histotoxic hypoxia in cultured cortical and hippocampal CA1 neurons. Acta Neuropathol 1996; 92: 541-544.
10. Gilman CP, Chan SL, Guo Z, Zhu X, Greig N, Mattson MP. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromolecular Med 2003; 3: 159-172.
11. Gottlieb TM, Oren M. p53 in growth control and neoplasia. Biochim Biophys Acta 1996; 7: 77-102.
12. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 1991; 15: 6961-6965.
13. Jordan J, Galindo MF, Gonzalez-Garcia C, Cena V. Role and regulation of p53 in depolarization-induced neuronal death. Neuroscience 2003; 122: 707-715.
14. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 21: 1132-1136.
15. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145: 1323-1336.
16. Lee MY, Kim SY, Shin SL, Choi YS, Lee JH, Tsujimoto Y, Lee JH. Reactive astrocytes express bis, a bcl-2-binding protein, after transient forebrain ischemia. Exp Neurol 2002; 175: 338-346.
17. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 14: 479-489.
18. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 24: 957-967.
19. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 1994; 120: 301-311.
20. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-17805.
21. Naganska E, Matyja E. Ultrastructural characteristics of necrotic and apoptotic mode of neuronal cell death in a model of anoxia in vitro. Folia Neuropathol 2001; 39: 129-139.
22. 2 pretreatment on the development of postanoxic neuronal damage in organotypic rat hippocampal cultures. Ultrastr Pathol 2002; 26: 383-391.
23. Renolleau S, Benjelloun N, Ben-Ari Y, Charriaut-Marlangue C. Regulation of apoptosis-associated proteins in cell death following transient focal ischemia in rat pups. Apoptosis 1997; 2: 368-376.
24. Rupniewska ZM, Rozynkowa D, Kurowska M. Rodzina genów bcl-2. Post Biol Kom 1997; 24: 33-47.
25. Sikora E. Mechanizmy śmierci programowanej komórek (apoptozy). Postepy Biochem 1994; 40: 150-160.
26. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 2003; 1: 45-58.
27. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
28. Wyllie AH. Apoptosis: an overview. British Medical Bulletin 1997; 53: 451-465.